ASX Small Cap Lunch Wrap: Who wants to ruin Father’s Day this year?

Here’s something that might just be a good idea for a Father’s Day present — or maybe not.

Darrell Lea has unveiled a limited edition brew flavoured like liquorice. It costs $11 per can, or $45 per four-pack drink.

If the liquorice-stout offering is indeed presented to any unsuspecting Dads this year, the unwritten rule is that they have to drink it. Haha.

If we’re being honest, the latest weird and wacky beer creation was an attempt on our part to lead off with something other than COVID.

However…

Overnight the US FDA gave full approval to the Pfizer COVID-19 jab, and some health experts are optimistic it will act as a catalyst to improve vaccination rates in the USA.

The news led to gains on Wall Street overnight and spurred demand for Australian travel stocks, even though there were no specific updates in the sector.

On the home-front, New South Wales surpassed six million jabs and looks set to grant its citizens more freedoms. While we’ll find out the details later in the week, travelling interstate is probably the least likely of them.

The ASX 200 followed the strong US lead to post a gain of 0.32% to 7,514 points as at 12pm.

 

WINNERS

Here are the best performing ASX small cap stocks at 12pm Tuesday, August 24:

Swipe or scroll to reveal the full table. Click headings to sort.

WordPress Table

Sitting on top with a gain of over 300% was Kuniko (ASX:KNI) which is a spin off from lithium high flyer Vulcan (ASX:VUL).

Speaking of hot running recent listees, Australian Rare Earths (ASX:AR3) surged further off the back of its latest drilling results.

Stocks climbing off the back of annual results included Nanosonics (ASX:NAN) and 1300 Smiles (ASX:ONT). The latter of these companies was further boosted from a $165 million takeover offer.

 

LOSERS

Here are the worst performing ASX small cap stocks at 12pm Tuesday, August 24:

Swipe or scroll to reveal the full table. Click headings to sort.

WordPress Table

Stocks which declined from their annual results included Monadelphous (ASX:MND) and Kogan (ASX:KGN).